This is an educational video that shows what skin looks like and other irregularities concerning the shape of the tumor. You will have understanding as to what the pathologist views under the scope to determine a person's diagnosis of melanoma.
This blog is educate those interested in knowing why testing is so important in the diagnosis and treatment of cancer and other blood disorders.
Thursday, December 22, 2011
Tuesday, December 20, 2011
Advancing Histology To Determine Cancer Diagnosis Video
Histology is extremely important in the diagnosis of all cancers. Tissues from biopsies procedures from any part of the body are processed in the histology department. After the tissues are processed the pathologist will view the prepared tissue on slides to determine if cancer is present.
Peter Kilner demonstrates a whole new way of approaching tissue processing with the Thermo Scientific Securesette cassette making it easier and more efficient to carry out biopsies and other tests in the histology lab. http://www.thermoscientific.com/pathology
Monday, December 19, 2011
Pancreatic Cancer Chemotherapy
John Chabot, MD, chief, division of GI/Endocrine Surgery, executive director, Pancreas Center at New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, discusses the current chemotherapy options available to treat pancreatic cancer. The main drug available is gemcitabine
and is currently used in combination therapies.
There are currently trials underway that are demonstrating improved survival with aggressive chemotherapy. Nongemcitabine regiment was identified that proved to be a better treatment option for stage IV pancreatic cancer than gemcitabine. Chabot expects that drugs that are used in other types of cancer will show the most significant improvement in the future.
and is currently used in combination therapies.
There are currently trials underway that are demonstrating improved survival with aggressive chemotherapy. Nongemcitabine regiment was identified that proved to be a better treatment option for stage IV pancreatic cancer than gemcitabine. Chabot expects that drugs that are used in other types of cancer will show the most significant improvement in the future.
Saturday, December 17, 2011
New Anti-Cancer Vaccine Developed by University of Georgia
By Joel Provano
The Atlanta Journal-Constitution
Researchers from the University of Georgia have developed a vaccine that has shown promising results against cancer, the UGA News Service is reporting.The vaccine dramatically reduced the size of tumors in laboratory mice and was particularly successful against breast and pancreatic tumors, two of the deadliest forms of cancer, the researchers reported.
"This vaccine elicits a very strong immune response," UGA researcher Geert-Jan Boons wrote. "It activates all three components of the immune system to reduce tumor size by an average of 80 percent."
The vaccine trains the immune system to distinguish and attack cancer cells based on their different chemical structures, said Sandra Gendler, a researcher at the Mayo Clinic in Arizona, which was also involved in the research.
"We are beginning to have therapies that can teach our immune system to fight what is uniquely found in cancer cells," Boons said. "When combined with early diagnosis, the hope is that one day cancer will become a manageable disease."
After further testing in the laboratory, clinical testing could begin in 2013, the researchers said.
Liver Cancer Video
This is a very informative video of liver cancer. You will learn about the functions of the liver,symptoms of liver cancer and treatment.
Video For Health
Video For Health
Friday, December 16, 2011
Histology of Bone Marrow Video
In the video you will learn what the pathologist is viewing in the bone marrow to determine the diagnosis of cancer or blood disorder.
Thursday, December 15, 2011
New Study Shows That HPV Test Is Better Than Pap Test for Cervical Cancer
HPV stands for Human Papillomavairus which is s the most common sexually transmitted virus in the United States. At least 50% of sexually active people will have genital HPV at some time in their lives.
A test that looks for the virus that causes most cases of cervical cancer may be the best way to screen women over age 30 for the disease, a new study shows.
The study followed 45,000 women ages 29 to 56 in the Netherlands who were split into two groups. The first group got a traditional Pap test to look for cervical cancer. The second group got a Pap test along with a newer test for human papillomavirus (HPV). Studies have shown that HPV causes more than 90% of all cervical cancers.
Five years after they were first screened, all women were rescreened using both Pap and HPV tests.
In the first round of testing, HPV tests detected significantly more precancerous changes to cervical cells than Pap testing alone.
Because doctors caught and treated those changes sooner, women who initially got HPV tests were less likely to have full-blown cervical cancer when they were tested again five years later compared to women who got Pap tests alone.
The study found that women who got an initial HPV test had about a 27% reduced risk of having advanced precancerous lesions five years later compared to women who had a Pap test alone.
They were also less likely to have cervical cancer. There were 14 cases of cancer found in the group that only got a Pap test at the start of the study compared to four cases in the women who also got an HPV test.
For more info:
http://www.webmd.com/cancer/cervical-cancer/news/20111215/hpv-test-beats-pap-test-cervical-cancer-screening
A test that looks for the virus that causes most cases of cervical cancer may be the best way to screen women over age 30 for the disease, a new study shows.
The study followed 45,000 women ages 29 to 56 in the Netherlands who were split into two groups. The first group got a traditional Pap test to look for cervical cancer. The second group got a Pap test along with a newer test for human papillomavirus (HPV). Studies have shown that HPV causes more than 90% of all cervical cancers.
Five years after they were first screened, all women were rescreened using both Pap and HPV tests.
In the first round of testing, HPV tests detected significantly more precancerous changes to cervical cells than Pap testing alone.
Because doctors caught and treated those changes sooner, women who initially got HPV tests were less likely to have full-blown cervical cancer when they were tested again five years later compared to women who got Pap tests alone.
The study found that women who got an initial HPV test had about a 27% reduced risk of having advanced precancerous lesions five years later compared to women who had a Pap test alone.
![]() |
HPV virus |
![]() | |
Mayo Clinic image of a woman with HPV |
http://www.webmd.com/cancer/cervical-cancer/news/20111215/hpv-test-beats-pap-test-cervical-cancer-screening
Subscribe to:
Posts (Atom)